Arbutus Announces Resignation of Board Member
WARMINSTER, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage
Globe Newswire27-01-2023, 19:32
Transmetrics Closes €2.5 Million Convertible Round to Accelerate the Development of AI-Driven Logistics Planning Technologies 23-02-2023, 14:00